Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder. [Phase 3]

View source ↗

Summary

This entry notes the completion of a Phase 3 trial evaluating risperidone added to mood stabilizers for manic episodes in bipolar disorder, compared with placeb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Bipolar Disorder, Manic Disorder | Phase 3 | Status: COMPLETED